Pharmacokinetics of praziquantel in healthy volunteers and patients with schistosomiasis

Transactions of the Royal Society of Tropical Medicine and Hygiene
M E MandourD W Harron

Abstract

The pharmacokinetics of a novel praziquantel preparation (Distocide) were investigated in Sudanese patients with hepatosplenic schistosomiasis and in healthy volunteers, and compared with those of Biltricide. The results of the first study indicated greater (P less than 0.05) plasma concentrations of Biltricide at 1.5, 2, 3 and 5 h after administration than with Distocide; plasma elimination half-lives (t 1/2) were not significantly different. In patients with hepatosplenic schistosomiasis, higher plasma levels of Distocide were noted (P less than 0.05 at 8 h) compared to healthy controls; however, due to wide inter-individual variations, there were no significant differences in maximum plasma concentration, time to maximum plasma concentration, area under the plasma concentration curve (AUC), volume of distribution, or clearance; t 1/2 was greater (P less than 0.05) in patients (11.9 +/- 5.4 h) than controls (2.3 +/- 0.4 h). In the presence of food, higher plasma concentrations of Distocide occurred compared to the fasting state; AUCs were greater (P less than 0.01) in both food groups, although the values of t 1/2 were shorter. The lower plasma levels and longer duration of action of Distocide may be advantageous in reducing ...Continue Reading

References

Mar 1, 1979·The American Journal of Tropical Medicine and Hygiene·D B HoffmanG Webbe
Jan 1, 1979·European Journal of Drug Metabolism and Pharmacokinetics·K PatzschkeH W Diekmann
Jun 1, 1975·Clinical Pharmacology and Therapeutics·M M Reidenberg, E S Vesell
Jan 1, 1986·Transactions of the Royal Society of Tropical Medicine and Hygiene·M M HomeidaJ L Bennet
Jan 1, 1988·The American Journal of Tropical Medicine and Hygiene·M HomeidaT E Nash
Sep 1, 1987·Revista Do Instituto De Medicina Tropical De São Paulo·A S da CunhaG L de Rezende
Sep 1, 1987·British Journal of Clinical Pharmacology·M M HomeidaD W Harron
Apr 1, 1987·Clinical Pharmacology and Therapeutics·T C FaganT E Gaffney
Sep 26, 1985·The New England Journal of Medicine·W G BerlingerR Spector
Oct 1, 1985·British Journal of Clinical Pharmacology·I el-RaghyM L Orme
Nov 1, 1982·Annals of Internal Medicine·T E NashJ A Cook
Jan 1, 1988·Parasitology Today·B L TekwanlS Ghatak

❮ Previous
Next ❯

Citations

Mar 31, 2012·European Journal of Drug Metabolism and Pharmacokinetics·Naglaa El-LakkanyLamia Heikal
Mar 13, 2013·Clinical Pharmacokinetics·Kyle J WilbyMary H H Ensom
Jan 1, 1995·Pharmacology & Therapeutics·D CioliS Archer
Jan 1, 1994·International Journal of Antimicrobial Agents·V Kumar, B Gryseels
Jan 1, 1995·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·A MetwallyG el D el attar
Nov 8, 2005·Transactions of the Royal Society of Tropical Medicine and Hygiene·K Na-BangchangJ Lazdins
Sep 19, 2000·Antimicrobial Agents and Chemotherapy·N CastroH Jung
Apr 24, 2003·Antimicrobial Agents and Chemotherapy·Jürg UtzingerBurton H Singer
Jan 7, 2014·The Journal of Antimicrobial Chemotherapy·Piero OlliaroJennifer Keiser
Nov 21, 2007·Journal of Clinical Pharmacy and Therapeutics·W RidtitidM Wongnawa
Sep 1, 1996·Gastroenterology Clinics of North America·D E Elliott
Jul 2, 2004·Annals of Tropical Medicine and Parasitology·K PengsaaA Subchareon
Mar 5, 2004·Expert Opinion on Pharmacotherapy·Jürg Utzinger, Jennifer Keiser
Oct 1, 1996·Pharmaceutical Development and Technology·S K el-Arini, H Leuenberger
Feb 15, 2005·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Raymond A Smego, Peter Sebanego
Mar 8, 2017·Antimicrobial Agents and Chemotherapy·Nuno ValeJosé M Correia da Costa
Sep 16, 2018·Journal of Pharmacokinetics and Pharmacodynamics·Peter L BonateJennifer Keiser
Jan 1, 1994·Biopharmaceutics & Drug Disposition·C M MasimirembwaJ A Hasler
Jan 10, 2019·Immunology and Cell Biology·Enwono EyohAnne L Astier
Feb 7, 2018·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Marike VisserDawn A Merritt
Apr 7, 2006·Expert Review of Anti-infective Therapy·Michael J Doenhoff, Livia Pica-Mattoccia
Feb 27, 2020·Clinical Pharmacokinetics·Valentin Al Jalali, Markus Zeitlinger
Mar 26, 1999·Movement Disorders : Official Journal of the Movement Disorder Society·A SchragW Poewe
Jul 8, 2020·Antimicrobial Agents and Chemotherapy·Amaya L BustinduyWilliam W Hope
Jun 12, 2019·Journal of Veterinary Pharmacology and Therapeutics·Zeynep OzdemirBunyamin Tras
Jun 7, 2020·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Marilyn N MartinezMatt Kuhn
Oct 1, 1994·Annals of Tropical Medicine and Parasitology·M HomeidaD W Harron
Feb 9, 2018·PLoS Neglected Tropical Diseases·Derick N M OsakunorFrancisca Mutapi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.